This interpretation is consistent with literature describing kidney–brain vulnerability and hemodynamic contributors to post-stroke AKI, and highlights the need to compare LAR with kidney-specific biomarkers (e.g., proenkephalin) in ICH cohorts (24–26). This evidence concerns the gene PENK and stroke disorder.